论文部分内容阅读
目的了解胰激肽释放酶对糖尿病患者左心室功能各项参数的影响。方法在用药前和用药后 3个月用彩色多普勒超声心动图测定左心室功能参数。结果与对照组相比 ,该药对心输出量、舒张早期最大充盈速度及舒张晚期充盈加速时间 ,用药后 3个月较用药前明显增加 (P <0 .0 5或P <0 .0 1) ,而舒张晚期最大充盈速度和舒张早期充盈加速时间用药后 3个月较用药前明显降低 (P <0 .0 1或P <0 .0 5 )。结论糖尿病患者服用胰激肽释放酶可改善左室舒张功能
Objective To investigate the effect of kallikrein on the parameters of left ventricular function in diabetic patients. Methods Left ventricular function parameters were measured by color Doppler echocardiography before medication and 3 months after treatment. Results Compared with the control group, the drug output of cardiac output, the maximum filling rate of early diastolic and the filling accelerated time of late diastolic phase were significantly increased at 3 months after treatment (P <0.05 or P <0.01) ), While the maximal late diastolic filling velocity and early diastolic filling acceleration time were significantly decreased 3 months after treatment (P <0.01 or P <0.05). Conclusion Diabetic patients taking pancreatic kallikrein can improve left ventricular diastolic function